Surrozen (SRZN) Current Assets (2020 - 2026)
Surrozen (SRZN) posted quarterly Current Assets of $113.9 million for Q1 2026, up 7.49% year-over-year from $106.0 million in Q1 2025, and up 24.45% quarter-over-quarter from $91.6 million in Q4 2025.
Surrozen (SRZN) Current Assets (2020 - 2026) Analysis & Trends
Surrozen's Current Assets history runs 7 years deep, the most recent figure standing at $113.9 million for Q1 2026.
- In Q1 2026, Current Assets rose 7.49% year-over-year to $113.9 million; the TTM figure through Mar 2026 stood at $113.9 million (up 7.49% YoY), while the FY2025 annual figure was $91.6 million, up 135.18% from the prior year.
- Current Assets for Q1 2026 stood at $113.9 million, up from $91.6 million in the prior quarter.
- The five-year high for Current Assets was $113.9 million in Q1 2026, with the low at $32.0 million in Q1 2024.
- The 5-year median for Current Assets is $81.3 million (2022), against an average of $71.7 million.
- The sharpest annual moves came in 2022 and 2024: Current Assets jumped 10234.74% in 2022, then sank 52.24% in 2024.
- Surrozen's Current Assets stood at $81.3 million in 2022, then sank by 49.41% to $41.1 million in 2023, then dropped by 5.35% to $38.9 million in 2024, then surged by 135.18% to $91.6 million in 2025, then gained by 24.45% to $113.9 million in 2026.
- Business Quant data shows SRZN's Current Assets at $113.9 million in Q1 2026, $91.6 million in Q4 2025, and $85.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Surrozen | 281.63 Mn | 281.63 Mn | - | 109.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 109.40 Mn |
| Mar 31, 2026 | 113.95 Mn |
| Dec 31, 2025 | 91.56 Mn |
| Sep 30, 2025 | 85.86 Mn |
| Jun 30, 2025 | 94.24 Mn |
| Mar 31, 2025 | 106.01 Mn |
| Dec 31, 2024 | 38.93 Mn |
| Sep 30, 2024 | 45.29 Mn |
| Jun 30, 2024 | 41.64 Mn |
| Mar 31, 2024 | 32.02 Mn |
| Dec 31, 2023 | 41.13 Mn |
| Sep 30, 2023 | 48.36 Mn |
| Jun 30, 2023 | 57.58 Mn |
| Mar 31, 2023 | 67.03 Mn |
| Dec 31, 2022 | 81.31 Mn |
| Sep 30, 2022 | 82.72 Mn |
| Jun 30, 2022 | 94.82 Mn |
| Mar 31, 2022 | 95.68 Mn |
| Dec 31, 2021 | 105.19 Mn |
| Sep 30, 2021 | 114.00 Mn |